Vol.

No.

October 31, 2014Oct 31, 2014

Free

DOWNLOAD THE PDF

How Elite Institutions were Affected By a Decade of Constricted Funding

Cover Story

Free

How Elite Institutions were Affected By a Decade of Constricted Funding

By Will Craft and Matthew Bin Han Ong

The ten-year period of erosion that followed the doubling of the NIH budget has hit some research institutions harder than others.

Free

The Impact of Triple Calamities: Flat Funding, the End of ARRA, & a Loss of Purchasing Power

By Matthew Bin Han Ong

Free Guest Editorial

The Academic Difference: George Weiner On How America's Cancer Centers Are More Valuable Than Ever

By George J. Weiner

Free

Bennett, Federal Prosecutors Reach $475,000 Settlement

By Paul Goldberg

In Brief

City of Hope Launches Blood Cancer Institute

Lisa Richardson named director of CDC Division of Cancer Prevention and Control

Milan Mrksich named associate director for research technology and infrastructure at Lurie Cancer Center

Ronan Swords receives Pap Corps Endowed Professorship

Laura Brod named CEO of GeneSegues Therapeutics

Merck Serono names three grant winners

Martine Extermann receives top award from International Society of Geriatric Oncology

Aptose Biosciences Inc. joins Beat AML consortium

Meridian Health and Hackensack University Health Network to discuss merging health systems

Knight Cancer Institute at Oregon Health and Science University launches statewide program

American Society of Clinical Oncology endorses AUA/ASTRO Guideline

Funding Opportunities

Leukemia & Lymphoma Society Launches Myeloid Program

Drugs & Targets

Lymphoseek Label Expanded To Include Mapping Solid Tumors

National Comprehensive Cancer Network approves VeriStrat predictive proteomics test

Myriad Genetics establishes European laboratory

Case Medical Center and Seidman Cancer Center select GenomOncology for workflow management

Qiagen and Astellas Pharma to collaborate on companion diagnostics

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

How Elite Institutions were Affected By a Decade of Constricted Funding

The Impact of Triple Calamities: Flat Funding, the End of ARRA, & a Loss of Purchasing Power

The Academic Difference: George Weiner On How America's Cancer Centers Are More Valuable Than Ever

Bennett, Federal Prosecutors Reach $475,000 Settlement

In Brief

City of Hope Launches Blood Cancer Institute

Lisa Richardson named director of CDC Division of Cancer Prevention and Control

Milan Mrksich named associate director for research technology and infrastructure at Lurie Cancer Center

Ronan Swords receives Pap Corps Endowed Professorship

Laura Brod named CEO of GeneSegues Therapeutics

Merck Serono names three grant winners

Martine Extermann receives top award from International Society of Geriatric Oncology

Aptose Biosciences Inc. joins Beat AML consortium

Meridian Health and Hackensack University Health Network to discuss merging health systems

Knight Cancer Institute at Oregon Health and Science University launches statewide program

American Society of Clinical Oncology endorses AUA/ASTRO Guideline

Funding Opportunities

Leukemia & Lymphoma Society Launches Myeloid Program

Drugs & Targets

Lymphoseek Label Expanded To Include Mapping Solid Tumors

National Comprehensive Cancer Network approves VeriStrat predictive proteomics test

Myriad Genetics establishes European laboratory

Case Medical Center and Seidman Cancer Center select GenomOncology for workflow management

Qiagen and Astellas Pharma to collaborate on companion diagnostics

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login